EIN: 880061894
UEI: N417AYXS9CC1
Audited by: CASEY NEILON, INC.
Oversight agency: 16 [Department of Justice]
View federal awards & risk assessment →
Data as of August 28, 2026
Management decision deadline — for entities that funded this organization
The FAC accepted this audit on March 9, 2026. Under 2 CFR 200.521(d), a pass-through entity that provided federal funds to this organization for this audit period must issue a management decision on these findings by September 9, 2026 (10 days from today).
What is a management decision? →The due date for a single audit submission is the earlier of 30 calendar days after the receipt of the audit report, or 9 months after the end of the audit period. The due date for the audit period ended June 30, 2024, was November 11, 2024. While the audit report was issued October 11, 2024 and uploaded to the Federal Clearing House shortly after, final certification was not made by the auditee until October 3, 2025.
Show full finding ▾Hide full finding ▴The due date for a single audit submission is the earlier of 30 calendar days after the receipt of the audit report, or 9 months after the end of the audit period. The due date for the audit period ended June 30, 2024, was November 11, 2024. While the audit report was issued October 11, 2024 and uploaded to the Federal Clearing House shortly after, final certification was not made by the auditee until October 3, 2025.
Management has put procedures in place in the current year to ensure timely submission.
FAC accepted this audit on October 3, 2025 — management decision was due April 3, 2026.
FAC accepted this audit on April 1, 2024 — management decision was due October 1, 2024.
FAC accepted this audit on March 23, 2023 — management decision was due September 23, 2023.
FAC accepted this audit on November 11, 2021 — management decision was due May 11, 2022.
FAC accepted this audit on December 1, 2020 — management decision was due June 1, 2021.
Reports between September 2019 and March 2020 were not timely filed. Cause: Nevada State Board of Pharmacy did not have adequate internal controls to ensure that the reports were timely filed. Effect: Reports are not timely filed. Questioned Costs: None reported. Context/Sampling: A nonstatistical sample of four monthly reports was selected. Repeat Finding from Prior Year: No. Recommendation: We recommend the Organization enhance the internal controls over reporting to ensure the reports are timely filed. Views of Responsible Officials: Nevada State Board of Pharmacy agrees with this finding.
Show full finding ▾Hide full finding ▴2020-002: Injury Prevention and Control Research and State and Community Based Programs, CFDA 93.136 US Department of Health and Human Services Passed through State of Nevada Division of Public and Behavior Health Reporting Significant Deficiency in Internal Control over Compliance and Noncompliance Grant Award Number: Affects all grant awards included under CFDA 93.136 on the Schedule of Expenditures of Federal Awards Criteria: The OMB Compliance Supplement provides that recipients are required to submit a monthly report by the 15th of the following month. Condition: Reports between September 2019 and March 2020 were not timely filed. Cause: Nevada State Board of Pharmacy did not have adequate internal controls to ensure that the reports were timely filed. Effect: Reports are not timely filed. Questioned Costs: None reported. Context/Sampling: A nonstatistical sample of four monthly reports was selected. Repeat Finding from Prior Year: No. Recommendation: We recommend the Organization enhance the internal controls over reporting to ensure the reports are timely filed. Views of Responsible Officials: Nevada State Board of Pharmacy agrees with this finding.
Finding 2020-002: US Department of Health and Human Services CFDA 93.136 Injury Prevention and Control Research and State and Community Finding Summary: Reports between September 2019 and March 2020 were not timely filed. Responsible Individual: Christian Schonlau, Chief Financial Officer Corrective Action Plan: Internal controls were updated to include process for monthly submission of funds reimbursement. Reimbursement request will be prepared for review by the Administrative Services Officer (ASO) no later than the 15th of each month for the preceding period. Reimbursement requests will be reviewed/approved by the CFO within three days of receipt, and will be submitted for reimbursement by the ASO no later than the last day of the month once approved. Anticipated Completion Date: April 1, 2020
Certain applicable provisions described in Appendix II to Part 200 were not included in contracts as required. Documentation of suspension debarment and appropriate sole source selection and justification was not retained. Procurement policy references the appropriate federal and state standards and do not address document flow, required approvals and internal controls. Cause: Nevada State Board of Pharmacy did not have adequate internal controls to ensure written contracts under Federal awards contained all of the applicable provisions and documentation of suspension debarment and appropriate sole source selection and justification is retained. Procurement policies do not address document flow, required approvals and internal controls. Effect: Contractors may not be aware of required terms and conditions; contracts may be entered into with vendors who are suspended or debarred. Federal and state standards for procurement may not be properly followed with appropriate oversight. Questioned Costs: None reported. Context/Sampling: All expenses which fell under the procurement standards. Repeat Finding from Prior Year: No. Recommendation: We recommend Nevada State Board of Pharmacy enhance internal controls to ensure all contracts under Federal awards contain all applicable provisions and proper documentation. Views of Responsible Officials: Nevada State Board of Pharmacy agrees with this finding.
Show full finding ▾Hide full finding ▴2020-003: Injury Prevention and Control Research and State and Community Based Programs, CFDA 93.136 US Department of Health and Human Services Passed through State of Nevada Division of Public and Behavior Health Procurement, Suspension, and Debarment Material Weakness in Internal Control over Compliance and Material Noncompliance Grant Award Number: Affects all grant awards included under CFDA 93.136 on the Schedule of Expenditures of Federal Awards. Criteria: Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) requires contracts contain the applicable provisions described in Appendix II to Part 200 for contracts under Federal awards. In addition, documentation of suspension debarment and appropriate sole source selection and justification is required. Procurement standards require that documented procurement procedures are retained and must maintain oversight for compliance with required standards. Condition: Certain applicable provisions described in Appendix II to Part 200 were not included in contracts as required. Documentation of suspension debarment and appropriate sole source selection and justification was not retained. Procurement policy references the appropriate federal and state standards and do not address document flow, required approvals and internal controls. Cause: Nevada State Board of Pharmacy did not have adequate internal controls to ensure written contracts under Federal awards contained all of the applicable provisions and documentation of suspension debarment and appropriate sole source selection and justification is retained. Procurement policies do not address document flow, required approvals and internal controls. Effect: Contractors may not be aware of required terms and conditions; contracts may be entered into with vendors who are suspended or debarred. Federal and state standards for procurement may not be properly followed with appropriate oversight. Questioned Costs: None reported. Context/Sampling: All expenses which fell under the procurement standards. Repeat Finding from Prior Year: No. Recommendation: We recommend Nevada State Board of Pharmacy enhance internal controls to ensure all contracts under Federal awards contain all applicable provisions and proper documentation. Views of Responsible Officials: Nevada State Board of Pharmacy agrees with this finding.
Finding 2020-003: US Department of Health and Human Services CFDA 93.136 Injury Prevention and Control Research and State and Community Finding Summary: Certain applicable provisions described in Appendix II to Part 200 were not included in contracts as required. Documentation of suspension debarment and appropriate sole source selection and justification was not retained. Procurement policy references the appropriate federal and state standards and do not address document flow, required approvals and internal controls. filed. Responsible Individual: Christian Schonlau, Chief Financial Officer Corrective Action Plan: Existing state and federal guidelines will be consolidated into the agency Internal controls, and be customized to specific roles to include document flow and approvals within the organization. Documentation of suspension and debarment as well as sole source selection will be retained in the agency contracts files. Anticipated Completion Date: March 30, 2021
Data source: This information comes from the Federal Audit Clearinghouse, the official repository of Single Audit data. All data is public domain. Verify this organization's audit history at fac.gov.
Browse other Single Audit organizations in Nevada →
Track your findings and corrective action plans across audit cycles.
Start tracking findings →Monitor subrecipient audit findings and filing records.
Start monitoring →© 2026 Single Audit Intelligence. All data is public domain.
